ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $868,479 | -20.5% | 289,493 | -0.9% | 0.00% | – |
| Q2 2023 | $1,092,420 | +84518.1% | 292,091 | -24.2% | 0.00% | – |
| Q1 2023 | $1,291 | -14.3% | 385,422 | +23.0% | 0.00% | -100.0% |
| Q4 2022 | $1,507 | -99.9% | 313,404 | -9.9% | 0.00% | 0.0% |
| Q3 2022 | $1,980,000 | +3.2% | 347,923 | +28.8% | 0.00% | 0.0% |
| Q2 2022 | $1,918,000 | +9.4% | 270,163 | +6.8% | 0.00% | 0.0% |
| Q1 2022 | $1,753,000 | -26.9% | 253,013 | -5.6% | 0.00% | 0.0% |
| Q4 2021 | $2,397,000 | -74.6% | 268,098 | -0.2% | 0.00% | -66.7% |
| Q3 2021 | $9,420,000 | +45.1% | 268,690 | -11.1% | 0.00% | +50.0% |
| Q2 2021 | $6,492,000 | +90.4% | 302,240 | +447.4% | 0.00% | +100.0% |
| Q1 2021 | $3,409,000 | +53.6% | 55,213 | +4.0% | 0.00% | 0.0% |
| Q4 2020 | $2,219,000 | – | 53,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 1,265,631 | $27,186,000 | 91.01% |
| Yu Fan | 143,867 | $3,090,000 | 34.92% |
| AJU IB Investment Co., Ltd. | 1,745,331 | $37,490,000 | 21.62% |
| Bain Capital Life Sciences Investors, LLC | 5,615,659 | $120,624,000 | 7.90% |
| Cormorant Asset Management, LP | 6,411,355 | $137,716,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 373,288 | $8,018,000 | 1.99% |
| RA Capital Management | 5,368,451 | $115,314,000 | 1.85% |
| Omega Fund Management, LLC | 746,868 | $16,043,000 | 1.82% |
| CM Management, LLC | 90,000 | $1,933,000 | 1.40% |
| SECTORAL ASSET MANAGEMENT INC | 538,884 | $11,575,000 | 0.94% |